Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
26
2024
M+ Check-Up: July 26, 2024 McDermott Will & Emery
Jul
26
2024
Pennsylvania Expands Access to Ready-to-Drink Cocktails McDermott Will & Emery
Jul
26
2024
Federal Court Dismisses $680 Million FCA Suit ArentFox Schiff LLP
Jul
26
2024
This Week in 340B: July 16 – 22, 2024 McDermott Will & Emery
Jul
26
2024
PFAS CERCLA Expansion Now On Hold CMBG3 Law
Jul
25
2024
Should the DEA Allow Providers to Prescribe Controlled Substances via Telehealth Means? Bradley Arant Boult Cummings LLP
Jul
25
2024
FDA Weighs In on Microplastics and Nanoplastics in Food K&L Gates
Jul
25
2024
How Does the End of Chevron Deference Change the Relationship Between the Health Care Industry, Federal Regulators, and Congress? Epstein Becker & Green, P.C.
Jul
25
2024
Ninth Circuit Clarifies the Ambiguity of Labeling and Claims Laws Keller and Heckman LLP
Jul
25
2024
Using AI for Worker Safety: Benefits and Risks Robinson & Cole LLP
Jul
25
2024
Preliminary Injunction Upheld in Cancer Relapse Detection Case McDermott Will & Emery
Jul
25
2024
Diagnosing Health Care Podcast – Episode 79: The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs [Podcast] Epstein Becker & Green, P.C.
Jul
25
2024
FDA Web Page Addresses Microplastics and Nanoplastics in Food Keller and Heckman LLP
Jul
25
2024
Clinical Trials: FDA Publishes Draft Guidance on Diversity Action Plans Foley & Lardner LLP
Jul
24
2024
China on the Move: Breaking Barriers and Accelerating Growth: Clinical Trials, Drug Approvals, and Cross-Border Data Transfers in Biotech Greenberg Traurig, LLP
Jul
24
2024
Episode 8: Innovation in Spine Health [Podcast] Blank Rome LLP
Jul
24
2024
More Delta-8 THC Foods Target of FDA and FTC Enforcement ArentFox Schiff LLP
Jul
24
2024
9th Circuit Holds that State Law Claims Identical to Federal Claims are Not Preempted Keller and Heckman LLP
Jul
23
2024
BETO’s Feedstock-Conversion Interface Consortium Intends to Issue Industrial Partnership Call in September 2024 Bergeson & Campbell, P.C.
Jul
23
2024
FDA Revisits and Updates Guidance on Addressing Misinformation – Ten Years Later Sheppard, Mullin, Richter & Hampton LLP
Jul
23
2024
CMS Sneaks 340B Billing Proposals into Medicare Physician Fee Schedule: What 340B Stakeholders Need to Know McDermott Will & Emery
Jul
23
2024
FSIS to Begin Testing for Allergens in Ready-To-Eat Foods Keller and Heckman LLP
Jul
23
2024
Not a Joy Ride: Navigating DUI Laws for Medical Cannabis Users in Pennsylvania Norris McLaughlin P.A.
Jul
22
2024
EC Seeks Applications for Newly Established Technology Council for Advanced Materials Bergeson & Campbell, P.C.
Jul
22
2024
FTC/FDA Send Letters to THC Edibles Companies Warning of Risks to Children Hunton Andrews Kurth
Jul
19
2024
FDA Pushes to Diversify Clinical Studies, Releases Draft Industry Guidance McDermott Will & Emery
Jul
19
2024
Texas Pharmaceutical Marketer Sentenced for $59 Million Medications Fraud Conspiracy ArentFox Schiff LLP
Jul
19
2024
The Accelerating Kids’ Access to Care Act: Breaking Barriers for Pediatric Patients Across State Lines ArentFox Schiff LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins